TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
1,259
|
1,120
|
1,148 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
58
|
29
|
31 |
| EBITDA |
76
|
48
|
32 |
| Total assets |
526
|
453
|
455 |
| Current assets |
468
|
381
|
453 |
| Current liabilities |
170
|
129
|
127 |
| Equity capital |
335
|
301
|
306 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
4
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
63.7%
|
66.4%
|
67.3% |
| Turnover per employee |
315
|
373
|
383 |
| Profit as a percentage of turnover |
4.6%
|
2.6%
|
2.7% |
| Return on assets (ROA) |
11.0%
|
6.4%
|
6.8% |
| Current ratio |
275.3%
|
295.3%
|
356.7% |
| Return on equity (ROE) |
17.3%
|
9.6%
|
10.1% |
| Change turnover |
180
|
75
|
10 |
| Change turnover % |
17%
|
7%
|
1% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.